These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 15210450

  • 1. Vasoconstriction in exercising skeletal muscles: a potential role for neuropeptide Y?
    Buckwalter JB, Hamann JJ, Kluess HA, Clifford PS.
    Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H144-9. PubMed ID: 15210450
    [Abstract] [Full Text] [Related]

  • 2. Vasoconstriction in active skeletal muscles: a potential role for P2X purinergic receptors?
    Buckwalter JB, Hamann JJ, Clifford PS.
    J Appl Physiol (1985); 2003 Sep; 95(3):953-9. PubMed ID: 12766177
    [Abstract] [Full Text] [Related]

  • 3. Neuropeptide Y1 receptor vasoconstriction in exercising canine skeletal muscles.
    Buckwalter JB, Hamann JJ, Clifford PS.
    J Appl Physiol (1985); 2005 Dec; 99(6):2115-20. PubMed ID: 16099895
    [Abstract] [Full Text] [Related]

  • 4. Role of nitric oxide in exercise sympatholysis.
    Buckwalter JB, Taylor JC, Hamann JJ, Clifford PS.
    J Appl Physiol (1985); 2004 Jul; 97(1):417-23; discussion 416. PubMed ID: 15020577
    [Abstract] [Full Text] [Related]

  • 5. Exercise attenuates alpha-adrenergic-receptor responsiveness in skeletal muscle vasculature.
    Buckwalter JB, Naik JS, Valic Z, Clifford PS.
    J Appl Physiol (1985); 2001 Jan; 90(1):172-8. PubMed ID: 11133908
    [Abstract] [Full Text] [Related]

  • 6. alpha1-adrenergic-receptor responsiveness in skeletal muscle during dynamic exercise.
    Buckwalter JB, Mueller PJ, Clifford PS.
    J Appl Physiol (1985); 1998 Dec; 85(6):2277-83. PubMed ID: 9843553
    [Abstract] [Full Text] [Related]

  • 7. Do P2X purinergic receptors regulate skeletal muscle blood flow during exercise?
    Buckwalter JB, Taylor JC, Hamann JJ, Clifford PS.
    Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H633-9. PubMed ID: 14551053
    [Abstract] [Full Text] [Related]

  • 8. alpha-adrenergic vasoconstriction in active skeletal muscles during dynamic exercise.
    Buckwalter JB, Clifford PS.
    Am J Physiol; 1999 Jul; 277(1):H33-9. PubMed ID: 10409179
    [Abstract] [Full Text] [Related]

  • 9. Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y.
    Modin A, Pernow J, Lundberg JM.
    Acta Physiol Scand; 1993 May; 148(1):1-11. PubMed ID: 8333291
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM, Modin A.
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [Abstract] [Full Text] [Related]

  • 11. NPY Y2 receptor agonist, N-acetyl [Leu28,Leu31]NPY24-36, reduces renal vasoconstrictor activity in anaesthetised dogs.
    Mahns DA, Kelly C, McCloskey DI, Potter EK.
    J Auton Nerv Syst; 1999 Oct 08; 78(1):10-7. PubMed ID: 10589818
    [Abstract] [Full Text] [Related]

  • 12. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.
    Lee EW, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo P, Sangkharat A, Ji H, Li L, Michalkiewicz T, Ljubisavljevic M, Johansson H, Grant DS, Zukowska Z.
    J Clin Invest; 2003 Jun 08; 111(12):1853-62. PubMed ID: 12813021
    [Abstract] [Full Text] [Related]

  • 13. In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle.
    Ekelund U, Erlinge D.
    Br J Pharmacol; 1997 Feb 08; 120(3):387-92. PubMed ID: 9031740
    [Abstract] [Full Text] [Related]

  • 14. Sympathetic vasoconstriction in active skeletal muscles during dynamic exercise.
    Buckwalter JB, Mueller PJ, Clifford PS.
    J Appl Physiol (1985); 1997 Nov 08; 83(5):1575-80. PubMed ID: 9375322
    [Abstract] [Full Text] [Related]

  • 15. Role of neuronal nitric oxide in the inhibition of sympathetic vasoconstriction in resting and contracting skeletal muscle of healthy rats.
    Jendzjowsky NG, DeLorey DS.
    J Appl Physiol (1985); 2013 Jul 01; 115(1):97-106. PubMed ID: 23640592
    [Abstract] [Full Text] [Related]

  • 16. Neuropeptide Y Y1 receptor mediated mesenteric vasoconstriction in the pig in vivo.
    Malmström RE.
    Regul Pept; 2000 Nov 24; 95(1-3):59-63. PubMed ID: 11062333
    [Abstract] [Full Text] [Related]

  • 17. Dynamic exercise attenuates sympathetic responsiveness of canine vascular smooth muscle.
    Ruble SB, Valic Z, Buckwalter JB, Clifford PS.
    J Appl Physiol (1985); 2000 Dec 24; 89(6):2294-9. PubMed ID: 11090581
    [Abstract] [Full Text] [Related]

  • 18. Neuropeptide Y and neurovascular control in skeletal muscle and skin.
    Hodges GJ, Jackson DN, Mattar L, Johnson JM, Shoemaker JK.
    Am J Physiol Regul Integr Comp Physiol; 2009 Sep 24; 297(3):R546-55. PubMed ID: 19571208
    [Abstract] [Full Text] [Related]

  • 19. The effect of aging on adrenergic and nonadrenergic receptor expression and responsiveness in canine skeletal muscle.
    Delorey DS, Clifford PS, Mittelstadt S, Anton MM, Kluess HA, Tune JD, Dincer UD, Buckwalter JB.
    J Appl Physiol (1985); 2012 Mar 24; 112(5):841-8. PubMed ID: 22194325
    [Abstract] [Full Text] [Related]

  • 20. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A.
    Acta Physiol Scand Suppl; 1994 Mar 24; 622():1-74. PubMed ID: 7524267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.